Valuation: Camlin Fine Sciences Limited

Market Cap 15.82B 166M 149M 137M 124M 232M 236M 1.64B 653M 8.28B 623M 610M 26.22B P/E 2027 *
20.6x
P/E 2028 * 10.2x
Enterprise Value 15.82B 166M 149M 137M 124M 232M 236M 1.64B 653M 8.28B 623M 610M 26.22B EV / Sales 2027 *
0.74x
EV / Sales 2028 * 0.65x
Free-Float
55.67%
Yield 2027 *
-
Yield 2028 * -
1 day+2.06%
1 week+4.59%
Current month-9.67%
1 month-9.67%
3 months-33.11%
6 months-33.80%
Current year-43.34%
1 week 79.01
Extreme 79.01
85.95
1 month 79
Extreme 79
98
Current year 79
Extreme 79
192
1 year 79
Extreme 79
202.55
3 years 79
Extreme 79
334.7
5 years 79
Extreme 79
334.7
10 years 33.4
Extreme 33.4
334.7
Manager TitleAgeSince
Chief Executive Officer 63 -
Chief Executive Officer 60 01/06/2021
Director of Finance/CFO - 18/08/2026
Director TitleAgeSince
Director/Board Member 60 04/08/2014
Chairman 63 17/06/2021
Director/Board Member 60 13/10/2017
Date Insider Type Main position Quantity % Market Cap. Importance
9/9/24
Infinity Holdings
SellCompany 1,338,600 0.7992%
9/9/24
Infinity Holdings
SellCompany 663,586 0.3962%
Change 5-day change 1-year change 3-year change Capi.($)
+2.06%+4.59%-57.17%-43.34% 166M
+2.89%+2.93%+16.85%+91.10% 84.34B
+1.90%-0.10%+19.97%+33.50% 43.75B
-0.10%-1.30%+13.21%-16.93% 34.63B
+2.44%+2.08%+13.41%+18.50% 33.66B
+0.74%-2.60%+19.92%+49.98% 32.38B
+0.75%+3.33%-1.71%+29.41% 26.34B
-0.65%-4.45%+50.95%+37.10% 23.89B
+1.37%+4.06%-42.97%-35.05% 18.98B
-4.36%0.00%+22.36%+10.33% 16.1B
Average +0.70%-0.47%+5.48%+17.46% 31.42B
Weighted average by Cap. +1.24%-0.01%+14.50%+38.05%

Financials

2027 *2028 *
Net sales 21.33B 224M 201M 185M 168M 313M 318M 2.21B 881M 11.16B 841M 823M 35.36B 24.35B 256M 229M 211M 191M 358M 363M 2.52B 1.01B 12.74B 960M 939M 40.36B
Net income 765M 8.03M 7.2M 6.64M 6.01M 11.23M 11.41M 79.2M 31.6M 400M 30.15M 29.51M 1.27B 1.56B 16.33M 14.63M 13.49M 12.21M 22.83M 23.2M 161M 64.22M 814M 61.28M 59.98M 2.58B
Net Debt - -
Projected Income Statement - Annual - Camlin Fine Sciences Limited
Logo Camlin Fine Sciences Limited
Camlin Fine Sciences Limited is an India-based specialty chemicals company, which is engaged in the research, development, manufacturing and marketing of specialty chemicals, ingredients, and additive blends. The Company's products portfolio is categorized into shelf-life solutions, performance chemicals, aroma ingredients, and health and wellness. Its products include catechol, tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), Ascorbyl Palmitate (ASP), 4-Tertiary Butyl Catechol, Xtendra, Guaiacol, Para DiMethoxy Benzene, NaSure, Hydroquinone, and Veratrole. Its aroma ingredients mainly include Vanillin, Ethyl Vanillin, and Natural Vanillin. The Company's products are used in varied industries, such as human food, animal feed, pet food, agrochemicals, petrochemicals, pharmaceuticals, nutraceuticals, flavors and fragrances, and health care. Its brands include Ezential, Nasure, adorr, Dinamics, Xtendra, and Biosus.
Employees
674
Date Price Change Volume
30/10/26 ₹84.05 +2.06% 151,426
29/10/26 ₹82.35 -1.96% 22,594
28/10/26 ₹84.00 +0.17% 50,404
27/10/26 ₹83.86 +0.60% 14,858
26/10/26 ₹83.36 +3.73% 96,858
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Camlin Fine Sciences Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
82.35INR
Average target price
152.50INR
Spread / Average Target
+85.19%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Camlin Fine Sciences Limited
  1. Stock Market
  2. Stocks
  3. CAMLINFINE Stock